Zobrazeno 1 - 10
of 205
pro vyhledávání: '"Roberto Sabbatini"'
Autor:
Maria Giuseppa Vitale, Cecilia Nasso, Beatrice Riccò, Alessandro Bocconi, Chiara Chiavelli, Cinzia Baldessari, Stefania Pipitone, Francesca Bacchelli, Laura Botticelli, Massimo Dominici, Roberto Sabbatini
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 564-572 (2024)
Introduction: Vaginal cancer is a rare gynecologic malignancy. While in a localized disease, concurrent chemoradiation grants local control and better overall survival, in a metastatic setting, the management options are very limited. Furthermore, re
Externí odkaz:
https://doaj.org/article/8508f19a4fed4db78fdb8f4292f8f7b8
Autor:
Eleonora Cabitza, Marta Pirola, Cinzia Baldessari, Giuditta Bernardelli, Elena Zunarelli, Stefania Pipitone, Maria Giuseppa Vitale, Cecilia Nasso, Eleonora Molinaro, Marco Oltrecolli, Elisa D’Agostino, Vincenzo Dario Mandato, Andrea Palicelli, Massimo Dominici, Roberto Sabbatini
Publikováno v:
Journal of Medical Case Reports, Vol 17, Iss 1, Pp 1-5 (2023)
Abstract Background Ovarian cancer is metastatic at presentation in about 62% of cases, but brain metastases are rare, reported in 3.3–4% of patients. Brain metastasis seems to be more frequent in advanced stages at diagnosis and in patients with B
Externí odkaz:
https://doaj.org/article/a4f5a6c85c3d401a928fbbcb6aa4d4bf
Autor:
Lucia Mangone, Francesco Marinelli, Isabella Bisceglia, Angelina Filice, Maria Barbara Braghiroli, Francesca Roncaglia, Andrea Palicelli, Fortunato Morabito, Antonino Neri, Roberto Sabbatini, Cinzia Iotti, Carmine Pinto
Publikováno v:
Biology, Vol 13, Iss 7, p 499 (2024)
The COVID-19 pandemic has caused delays in cancer diagnoses and reductions in treatments. The aim of this work is to evaluate the impact of the pandemic on prostate cancer by evaluating whether there has been a shift towards more aggressive (Gleason)
Externí odkaz:
https://doaj.org/article/4b29f2c1aea74b41ab7fe97a66604e90
Autor:
Claudia Piombino, Stefania Pipitone, Elena Tonni, Luciana Mastrodomenico, Marco Oltrecolli, Cyrielle Tchawa, Rossana Matranga, Sara Roccabruna, Elisa D’Agostino, Marta Pirola, Francesca Bacchelli, Cinzia Baldessari, Maria Cristina Baschieri, Massimo Dominici, Roberto Sabbatini, Maria Giuseppa Vitale
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 9, p 4624 (2024)
More than 20% of metastatic prostate cancer carries genomic defects involving DNA damage repair pathways, mainly in homologous recombination repair-related genes. The recent approval of olaparib has paved the way to precision medicine for the treatme
Externí odkaz:
https://doaj.org/article/eaeacfb0992c4dc6b00b1ed357bf4eb5
Autor:
Domenica Lorusso, Romano Danesi, Laura Deborah Locati, Gianluca Masi, Ugo De Giorgi, Angiolo Gadducci, Sandro Pignata, Roberto Sabbatini, Antonella Savarese, Giorgio Valabrega, Claudio Zamagni, Nicoletta Colombo
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/01160f11902f41b39a39a31497957622
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/25d1143cdfd240d1bb7dd329ed07996f
Autor:
Luca Urso, Luca Filippi, Angelo Castello, Maria Cristina Marzola, Mirco Bartolomei, Corrado Cittanti, Luigia Florimonte, Massimo Castellani, Paolo Zucali, Alessio Bruni, Roberto Sabbatini, Massimo Dominici, Stefano Panareo, Laura Evangelista
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 22, p 7130 (2023)
Background: prostate-specific membrane antigen (PSMA) ligand PET has been recently incorporated into international guidelines for several different indications in prostate cancer (PCa) patients. However, there are still some open questions regarding
Externí odkaz:
https://doaj.org/article/6f270d25d81d4eaaa799d22e7675cf72
Autor:
Claudia Piombino, Marco Oltrecolli, Elena Tonni, Marta Pirola, Rossana Matranga, Cinza Baldessari, Stefania Pipitone, Massimo Dominici, Roberto Sabbatini, Maria Giuseppa Vitale
Publikováno v:
Cancers, Vol 15, Iss 20, p 4945 (2023)
De novo metastatic hormone-sensitive PC (mHSPC) accounts for 5–10% of all prostate cancer (PC) diagnoses but it is responsible for nearly 50% of PC-related deaths. Since 2015, the prognosis of mHSPC has slightly improved thanks to the introduction
Externí odkaz:
https://doaj.org/article/b249130b8e9d487eb8b94a12d82c66a9
Chasing the Role of miRNAs in RCC: From Free-Circulating to Extracellular-Vesicle-Derived Biomarkers
Autor:
Ilenia Mastrolia, Virginia Catani, Marco Oltrecolli, Stefania Pipitone, Maria Giuseppa Vitale, Valentina Masciale, Chiara Chiavelli, Carlo Augusto Bortolotti, Cecilia Nasso, Giulia Grisendi, Roberto Sabbatini, Massimo Dominici
Publikováno v:
Biology, Vol 12, Iss 6, p 877 (2023)
Renal cell carcinoma (RCC) is the second most common cancer of the urinary system. The current therapeutic strategies are based on partial or total nephrectomy and/or targeted therapies based on immune checkpoint inhibitors to which patients are ofte
Externí odkaz:
https://doaj.org/article/cee52440245645c9808ead623d8c9f55
Autor:
Domenica Lorusso, Romano Danesi, Laura Deborah Locati, Gianluca Masi, Ugo De Giorgi, Angiolo Gadducci, Sandro Pignata, Roberto Sabbatini, Antonella Savarese, Giorgio Valabrega, Claudio Zamagni, Nicoletta Colombo
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionThe combination of lenvatinib plus pembrolizumab demonstrated a relevant clinical benefit in patients with endometrial carcinoma. The safety profile was consistent with the established profiles of each drug in monotherapy, with the most f
Externí odkaz:
https://doaj.org/article/3326d4a85d0b488b9f8013eaaad98244